[Combination of a synthetic anticholinergic agent and various enzymes (amylases, lipases, proteases, hemicellulases and cellulases) in the treatment of enteropathies].
D000681:Amylases / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006026:Glycoside Hydrolases / Q000627:therapeutic use; D006801:Humans; D006867:Hydrolases / Q000627:therapeutic use*; D007410:Intestinal Diseases / Q000188:drug therapy*; D008049:Lipase / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D010447:Peptide Hydrolases / Q000627:therapeutic use
D010276:Parasympatholytics; D006867:Hydrolases; D008049:Lipase; D000681:Amylases; D006026:Glycoside Hydrolases; D010447:Peptide Hydrolases
L'association d'un anticholinergique de synthèse et d'enzymes diverses (amylases, lipases, protéases, hémicellulases et cellulases) dans le traitement des entéropathies.